In vivocontrolled release and prolonged antitumor effects of 2-methoxyestradiol solid lipid nanoparticles incorporated into a thermosensitive hydrogel-Reference-Cited by-同舟云学术

In vivocontrolled release and prolonged antitumor effects of 2-methoxyestradiol solid lipid nanoparticles incorporated into a thermosensitive hydrogel

Published:2012-05 Issue:4 Volume:19 Page:188-193
ISSN:1071-7544
Container-title:Drug Delivery
language:en
Short-container-title:Drug Delivery

Author:

Guo XinHong,Xing YaBing,Zhang XinXin,Li JunMei,Mei Qian,Zhang HongLing,Chen ChengQun,Zhang ZhenZhong,Cui FuDe

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/10717544.2012.690002

Reference21 articles.

1. Pharmacokinetic and pharmacodynamic evaluation of a novel in situ forming poly(ethylene glycol)-based hydrogel for the controlled delivery of the camptothecins

2. Cellular uptake and cytotoxicity of solid lipid nanospheres (SLN) incorporating doxorubicin or paclitaxel

3. Thermosensitive chitosan-based hydrogel containing liposomes for the delivery of hydrophilic molecules

4. Prevention of metastasis in a 4T1 murine breast cancer model by doxorubicin carried by folate conjugated pH sensitive polymeric micelles

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fluorescent nanocomposites loaded hydrogels as a theranostic platform for advanced healthcare applications: Recent trends and opportunities;European Polymer Journal;2023-09

2. Lipid Nanocarriers for Breast Cancer Treatment;Cancer Nanotechnology;2022-12-14

3. In Situ Hydrogels for Effective Treatment of Cancer: Strategies and Polymers Used;Recent Advances in Drug Delivery and Formulation;2022-12

4. Multiple local therapeutics based on nano-hydrogel composites in breast cancer treatment;Journal of Materials Chemistry B;2021

5. High oral bioavailability of 2-methoxyestradiol in PEG-PLGA micelles-microspheres for cancer therapy;European Journal of Pharmaceutics and Biopharmaceutics;2017-08